ResCare Announces Expiration of Consent Payment Deadline and Execution of Supplemental Indenture Related to Its 7 3/4% Senior No
23 December 2010 - 8:39AM
ResCare, Inc. ("ResCare") (Nasdaq:RSCR) today announced the
expiration of the consent payment deadline for its previously
announced cash tender offer for any and all of its outstanding 7
3/4% Senior Notes due 2013 (the "Notes") and the related consent
solicitation (the "Offer") as of 5:00 p.m., New York City time, on
December 21, 2010 (the "Consent Payment Deadline"). As of the
Consent Payment Deadline, a total of $120,046,000 of Notes,
representing approximately 80.0% of the outstanding Notes, have
been validly tendered and not withdrawn pursuant to the Offer to
Purchase and Consent Solicitation Statement dated December 6, 2010
(the "Offer to Purchase"). ResCare made payment in respect of
the tendered Notes today (the "Initial Payment Date").
ResCare also announced the execution of the supplemental
indenture (the "Supplemental Indenture") related to its previously
announced consent solicitations (the "Consent Solicitations") for
amendments to the Notes and the indenture governing the Notes (the
"Indenture"). The Supplemental Indenture was executed after
receipt of consents from the holders of a majority in principal
amount of the Notes. The amendments eliminate substantially
all of the restrictive covenants and certain events of default from
the Indenture governing the Notes and have become operative.
As described in the Offer to Purchase, Holders who validly
tender their Notes after the Consent Payment Deadline and prior to
11:59 p.m., New York City time, on January 4, 2011, unless extended
(the "Expiration Time") will be eligible to receive an amount, paid
in cash, equal to $991.88 for each $1,000 of Notes plus accrued and
unpaid interest to but excluding the final payment date for the
Offer.
As contemplated by the Offer to Purchase, ResCare further
announced that it has called for redemption on January 21, 2011
(the "Redemption Date") all Notes not accepted for payment in the
Offer (the "Redeemed Notes"). On the Redemption Date, the
redemption price of $1,019.38 per $1,000 principal amount of the
Redeemed Notes provided in the Indenture governing the Notes will
become due and payable together with accrued and unpaid interest to
the Redemption Date in an amount equal to $20.45 per $1,000
principal amount of the Redeemed Notes. The Redeemed Notes
must be surrendered at the office of the trustee for holders of the
Notes to collect the redemption price.
J.P. Morgan Securities LLC and BofA Merrill Lynch are the Dealer
Managers for the Offer. The depositary is Computershare Trust
Company, N.A., and the information agent is Georgeson
Inc. Questions or requests for assistance may be directed to
J.P. Morgan Securities LLC at (212) 270-1200 (collect) or (800)
245-8812 (toll free), or to BofA Merrill Lynch at (980) 388-9217
(collect) or (888) 292-0070 (toll free), or to Georgeson Inc. at
(866) 203-9357.
This release is for informational purposes only and is neither
an offer to purchase nor a solicitation of an offer to sell the
Notes. The offer to buy the Notes is only being made pursuant
to the tender offer and consent solicitation documents, including
the Offer to Purchase and Consent Solicitation Statement that
ResCare distributed to holders of the Notes. The tender offer
and consent solicitation is not being made to holders of Notes in
any jurisdiction in which the making or acceptance thereof would
not be in compliance with the securities, blue sky or other laws of
such jurisdiction. In any jurisdiction in which the tender
offer or consent solicitation is required to be made by a licensed
broker or dealer, they shall be deemed to be made by J.P. Morgan
Securities LLC and BofA Merrill Lynch or one or more registered
brokers or dealers on behalf of ResCare.
About ResCare
ResCare, founded in 1974, offers services to some 60,000 people
in 41 states, Washington, DC, Puerto Rico and certain international
locations. ResCare is a human services company that provides
residential, therapeutic, job training and educational supports to
people with developmental or other disabilities, to elderly people
who need in-home care, to youths with special needs and to adults
who are experiencing barriers to employment. The Company is
based in Louisville, Kentucky.
The Company from time to time makes forward-looking statements
in its public disclosures, including statements relating to
revenues that might be expected from new or acquired programs and
facilities, other statements regarding development and acquisition
activities, statements regarding reimbursement under federal and
state programs and statements regarding various trends favoring
downsizing, deinstitutionalization and privatization of government
programs. These statements include, but are not limited to,
statements relating to the offering of the Notes and the
anticipated use of proceeds therefrom. In the Company's
filings under the federal securities laws, including its annual,
periodic and current reports, the Company identifies important
factors that could cause the Company's results to differ materially
from those contained in such forward-looking
statements. Please refer to those disclosures.
This press release is not an offer to purchase or a solicitation
of an offer to sell securities, including the Notes.
CONTACT: ResCare, Inc.
David W. Miles, Chief Financial Officer
502-394-2137
Res-Care, Inc. (MM) (NASDAQ:RSCR)
Historical Stock Chart
From Oct 2024 to Nov 2024
Res-Care, Inc. (MM) (NASDAQ:RSCR)
Historical Stock Chart
From Nov 2023 to Nov 2024